Stephen Hoge
CIK: 0001760669
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Moderna, Inc.
Discretionary Trading P&L
Holdings
Transaction History (83 total)
- Oct 15, 2026MRNA
Moderna, Inc.
Sale(S)Direct39.1K shares at avg. $220.72$8.6M - Oct 15, 2026MRNA
Moderna, Inc.
Exercise(M)Direct76.5K shares at avg. $12.21$933K - Oct 14, 2026MRNA
Moderna, Inc.
Sale(S)Direct38.8K shares at avg. $213.47$8.3M - Oct 14, 2026MRNA
Moderna, Inc.
Sale(S)Direct450 shares at avg. $214.15$96K - Oct 14, 2026MRNA
Moderna, Inc.
Exercise(M)Direct76.5K shares at avg. $12.21$933K - Sep 15, 2026MRNA
Moderna, Inc.
Sale(S)Direct40.3K shares at avg. $146.07$5.9M - Sep 15, 2026MRNA
Moderna, Inc.
Exercise(M)Direct76.5K shares at avg. $12.21$933K - Sep 14, 2026MRNA
Moderna, Inc.
Exercise(M)Direct76.5K shares at avg. $12.21$933K - Sep 14, 2026MRNA
Moderna, Inc.
Sale(S)Direct40.3K shares at avg. $144.13$5.8M - Sep 1, 2026MRNA
Moderna, Inc.
Exercise(M)Direct9.3K shares- - Sep 1, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct4.5K shares at avg. $140.34$630K - Aug 28, 2026MRNA
Moderna, Inc.
Exercise(M)Direct611 shares- - Aug 28, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct296 shares at avg. $142.77$42K - Aug 27, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct695 shares at avg. $149.66$104K - Aug 27, 2026MRNA
Moderna, Inc.
Exercise(M)Direct1.4K shares- - Jul 15, 2026MRNA
Moderna, Inc.
Sale(S)Direct53.3K shares at avg. $67.60$3.6M - Jul 15, 2026MRNA
Moderna, Inc.
Exercise(M)Direct16.1K shares at avg. $19.15$309K - Jul 15, 2026MRNA
Moderna, Inc.
Exercise(M)Direct37.2K shares at avg. $19.15$713K - Jun 15, 2026MRNA
Moderna, Inc.
Exercise(M)Direct16.1K shares at avg. $19.15$309K - Jun 15, 2026MRNA
Moderna, Inc.
Exercise(M)Direct37.2K shares at avg. $19.15$713K - Jun 15, 2026MRNA
Moderna, Inc.
Sale(S)Direct53.3K shares at avg. $51.37$2.7M - Jun 1, 2026MRNA
Moderna, Inc.
Exercise(M)Direct9.3K shares- - Jun 1, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct4.5K shares at avg. $47.19$212K - May 28, 2026MRNA
Moderna, Inc.
Exercise(M)Direct610 shares- - May 28, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct295 shares at avg. $47.61$14K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | MRNA Moderna, Inc. | Sale(S) | 39,145 | $220.72 | $8,640,084 | Direct |
| Oct 15, 2026 | MRNA Moderna, Inc. | Exercise(M) | 76,452 | $12.21 | $933,479 | Direct |
| Oct 14, 2026 | MRNA Moderna, Inc. | Sale(S) | 38,774 | $213.47 | $8,277,086 | Direct |
| Oct 14, 2026 | MRNA Moderna, Inc. | Sale(S) | 450 | $214.15 | $96,368 | Direct |
| Oct 14, 2026 | MRNA Moderna, Inc. | Exercise(M) | 76,453 | $12.21 | $933,491 | Direct |
| Sep 15, 2026 | MRNA Moderna, Inc. | Sale(S) | 40,281 | $146.07 | $5,883,846 | Direct |
| Sep 15, 2026 | MRNA Moderna, Inc. | Exercise(M) | 76,452 | $12.21 | $933,479 | Direct |
| Sep 14, 2026 | MRNA Moderna, Inc. | Exercise(M) | 76,453 | $12.21 | $933,491 | Direct |
| Sep 14, 2026 | MRNA Moderna, Inc. | Sale(S) | 40,294 | $144.13 | $5,807,574 | Direct |
| Sep 1, 2026 | MRNA Moderna, Inc. | Exercise(M) | 9,283 | - | $0 | Direct |
| Sep 1, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 4,489 | $140.34 | $629,986 | Direct |
| Aug 28, 2026 | MRNA Moderna, Inc. | Exercise(M) | 611 | - | $0 | Direct |
| Aug 28, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 296 | $142.77 | $42,260 | Direct |
| Aug 27, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 695 | $149.66 | $104,014 | Direct |
| Aug 27, 2026 | MRNA Moderna, Inc. | Exercise(M) | 1,437 | - | $0 | Direct |
| Jul 15, 2026 | MRNA Moderna, Inc. | Sale(S) | 53,336 | $67.60 | $3,605,514 | Direct |
| Jul 15, 2026 | MRNA Moderna, Inc. | Exercise(M) | 16,110 | $19.15 | $308,507 | Direct |
| Jul 15, 2026 | MRNA Moderna, Inc. | Exercise(M) | 37,226 | $19.15 | $712,878 | Direct |
| Jun 15, 2026 | MRNA Moderna, Inc. | Exercise(M) | 16,110 | $19.15 | $308,507 | Direct |
| Jun 15, 2026 | MRNA Moderna, Inc. | Exercise(M) | 37,226 | $19.15 | $712,878 | Direct |
| Jun 15, 2026 | MRNA Moderna, Inc. | Sale(S) | 53,336 | $51.37 | $2,739,870 | Direct |
| Jun 1, 2026 | MRNA Moderna, Inc. | Exercise(M) | 9,282 | - | $0 | Direct |
| Jun 1, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 4,488 | $47.19 | $211,789 | Direct |
| May 28, 2026 | MRNA Moderna, Inc. | Exercise(M) | 610 | - | $0 | Direct |
| May 28, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 295 | $47.61 | $14,045 | Direct |
1-25 of 83 transactions
About Hoge Stephen
Hoge Stephen (SEC CIK 0001760669) files insider reports with the SEC as President of Moderna, Inc. (MRNA).
Signal8 holds 26 ownership filings by Hoge Stephen, all Form 4s, filed between Sep 4, 2024 and Oct 16, 2026. Those filings report 83 transactions, from Aug 30, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hoge Stephen's filings is in CAMBRIDGE, MA.
Recent filings by Hoge Stephen
- Oct 15, 2026: Open-market sale of MRNA shares (Form 4, code S).
- Oct 15, 2026: Option exercise of MRNA shares (Form 4, code M).
- Oct 14, 2026: Open-market sales of MRNA shares (2 lines, Form 4, code S).
- Oct 14, 2026: Option exercise of MRNA shares (Form 4, code M).
- Sep 15, 2026: Open-market sale of MRNA shares (Form 4, code S).
Other insiders filing for Moderna, Inc. (MRNA)
- Mock James M, Chief Financial Officer
- Andres Juan, Chief Operating Officer
- Klinger Shannon Thyme, Chief Legal Officer
- Bancel Stephane, Chief Executive Officer
- McDonnell Michael R., Director
- Banque Soria Ester, Chief Commercial Officer